Drugs / Silver Nitrate
Silver Nitrate
also known as
AgNO3 · Argentum nitricum · Bacillinum · Carcinocin · HEPAR SULPHUR · Hyoscymus · Kali Bromatum · Lac Vaccininum · +4 more
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02604134 | Jul 2014 → Aug 2017 | dental caries | Arwa Owais | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03781908 | Jan → Dec 2019 | thoracic cancer | Assiut University | Unknown | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT06363539 | Sep 2022 → Mar 2023 | pyogenic granuloma | Children Hospital and Institute of Child Health, Lahore | Completed | No outcome recorded |
| Phase 2 | NCT01125124 | Aug 2009 → Dec 2010 | pleural neoplasm | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00675922 | Jul 1995 → May 2008 | — | The University of Texas Medical Branch, Galveston | Terminated | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02019160 | Sep 2014 → Jun 2018 | dental caries | The University of Hong Kong | Completed | No outcome recorded |
| Phase 3 | NCT00000120 | Jan 1985 → ? | chlamydia trachomatis infectious disease, ophthalmia neonatorum | National Eye Institute (NEI) | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT03920306 | Apr 2019 → Sep 2024 | gastrocutaneous syndrome | University of British Columbia | Completed | No outcome recorded |
| Phase 4 | NCT07054697 | Jan 2017 → Dec 2024 | autism spectrum disorder | Aditi Chadha | Completed | No outcome recorded |
| Phase 4 | NCT07161804 | Dec 2016 → Dec 2024 | autism spectrum disorder | Holistic Homoeopathic Clinic and Research Center | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06836791 | Mar 2023 → Oct 2024 | — | Youssef Zaki | Completed | No outcome recorded |
Also used as a comparator or background therapy in 8 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06681194 Comparator | Jun 2025 → Dec 2028 expected | — | Francesco Egro | Not yet recruiting | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT03423797 Comparator | Sep 2017 → May 2020 | dental caries | The University of Hong Kong | Completed | No outcome recorded |
| Phase 3 | NCT02519738 Comparator | Jan 2015 → Nov 2018 | — | University of Michigan | Terminated | No outcome recorded |
| Phase 3 | NCT01996930 Comparator | Dec 2013 → Mar 2017 | chronic renal failure syndrome, end stage renal failure | University Hospital Birmingham NHS Foundation Trust | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT04560049 Comparator | Jun 2020 → Jun 2022 | pilonidal sinus | Umraniye Education and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02398539 Comparator | Apr → Dec 2015 | pyogenic granuloma | Akron Children's Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02116608 Comparator | Sep 2014 → Sep 2019 | tracheal disorder | University of Colorado, Denver | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06629558 Comparator | Oct 2024 → Dec 2025 overdue | — | Mansoura University Hospital | Recruiting | No outcome recorded |
Evidence & citations 15 cited values
Every value below carries the sentence it was read from. 20 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | silver nitrate | “Children in group A received a semiannual application of a 25% silver nitrate (AgNO3) solution followed by a commercially available varnish with 5% sodium fluoride (NaF) on the...” PMID 32866050 ↗ Aug 202017“a 25% silver nitrate (AgNO3) solution followed by a 5% sodium fluoride (NaF) varnish” PMID 30931709 ↗ Feb 2019 “silver nitrate” NCT02019160 ↗ “Silver Nitrate” NCT03920306 ↗ |
| Known as | AgNO3 | “Children in group A received a semiannual application of a 25% silver nitrate (AgNO3) solution followed by a commercially available varnish with 5% sodium fluoride (NaF) on the...” PMID 32866050 ↗ Aug 20201“a 25% silver nitrate (AgNO3) solution followed by a 5% sodium fluoride (NaF) varnish” PMID 30931709 ↗ Feb 2019 |
| Known as | AMBER GRISEA | “AMBER GRISEA” NCT07054697 ↗ |
| Known as | Argentum nitricum | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“ARGENTUM NITRICUM” NCT07054697 ↗ |
| Known as | Bacillinum | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“BACILLINUM” NCT07054697 ↗ |
| Known as | Carcinocin | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“CARCINOCIN” NCT07054697 ↗ |
| Known as | HEPAR SULPHUR | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“HEPAR SULPHUR” NCT07054697 ↗ |
| Known as | Hyoscymus | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“HYOSCYMUS” NCT07054697 ↗ |
| Known as | Kali Bromatum | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“KALI BROMATUM” NCT07054697 ↗ |
| Known as | Lac Vaccininum | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“LAC VACCININUM” NCT07054697 ↗ |
| Known as | SNS | “Silver nitrate solution (SNS) is a valid sclerosing agent” NCT03781908 ↗ |
| Known as | THUJA OFFICINALIS | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“THUJA OFFICINALIS” NCT07054697 ↗ |
| Known as | Vaccininum | “Thuja officinalis Vaccininum Causticum Argentum nitricum Tuberculinum Stramonium Staphysagria Arum triphyllum Bacillinum Cina Carcinocin Cuprum Metallicum Ambera grisea...” NCT07161804 ↗1“VACCININUM” NCT07054697 ↗ |
| Modality | Other / unclassified | “two types of irritating agent for pilonidal sinus disesase. One of them is phenol and second one is silver nitrate solution.” NCT04560049 ↗ |
| Route | Other | “through the pleural catheter” NCT01125124 ↗ |